Necroptosis-IN-1

CAS No. 1391980-92-9

Necroptosis-IN-1 ( —— )

Catalog No. M23550 CAS No. 1391980-92-9

Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 122 In Stock
5MG 178 In Stock
10MG 295 In Stock
25MG 502 In Stock
50MG 709 In Stock
100MG 1008 In Stock
500MG 2007 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Necroptosis-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.
  • Description
    Necroptosis-IN-1 is a potent necroptosis inhibitor of RIPK1. It is an analog of Necrostatin-1.
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    RIP kinase
  • Recptor
    RIPK1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1391980-92-9
  • Formula Weight
    263.7
  • Molecular Formula
    C12H10ClN3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 249 mg/mL (944.32 mM; Need ultrasonic)
  • SMILES
    O=C(C(Cc(c1ccc2)c[nH]c1c2Cl)N1)NC1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jenny L Maki, et al. Fluorescence polarization assay for inhibitors of the kinase domain of receptor interacting protein 1. Anal Biochem. 2012 Aug 15;427(2):164-74.
molnova catalog
related products
  • CSLP37

    CSLP37 (RIPK2 inhibitor CSLP37) is a novel potent, ATP pocket-binding RIPK2 inhibitor with IC50 of 16.3 nM in ADPGlo assay.

  • Necrostatin-34

    Necrostatin-34 is a RIPK1 kinase inhibitor, stabilizing RIPK1 kinase in an inactive conformation by occupying a distinct binding pocket in the kinase domain.

  • GSK-481

    A highly potent, monokinase selective and ATP-competitive inhibitor of RIP1 kinase with biochemical IC50 of 10 nM.